INSERM Transfert SA (extinct)

INSERM Transfert SA (extinct)

INSERM Transfert SA (extinct)

Overview
Date Founded

2000

Headquarters

7, rue Watt,Paris, Ile-de-France 75013

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing.ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.

Website

http://www.inserm-transfert.com

Contact Data
Trying to get in touch with decision makers at INSERM Transfert SA? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
August 29, 2019
The Antibody Drug Conjugates Market is Projected to be Worth More Than USD 15 Billion by 2030, Growing at a CAGR of Over 20%, Claims Roots Analysis
GlobeNewswire
February 6, 2019
Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure
ENP Newswire
August 30, 2018
-University of Cambridge Research : Electronic device implanted in the brain could stop seizures
Business Wire
August 27, 2018
Predicting the Response to Immunotherapy Using Artificial Intelligence
PR Newswire
October 17, 2017
Genisphere Pursues Neurotherapeutics under Collaboration Agreement with Inserm

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Trending People
National Basketball Association, Inc.
NBA All-Star Game Honors Life and Legacy of Kobe Bryant - Time Magazine
Democratic Party
Democratic hopefuls now test strength among minority voters - St. Paul Pioneer Press (Minnesota)
The United States Social Security Administration
Union for Reform Judaism, Central Conference of American Rabbis Issue Joint Publ... - Targeted News Service
United States Environmental Protection Agency
Pima offers to swap gas-powered mowers for vouchers - The Arizona Daily Star
Federal Bureau of Investigation
Trump doesn’t heed Barr’s request to cool tweeting on DOJ - The Salt Lake Tribune
Trending Organizations
National Basketball Association, Inc.
NBA All-Star Game Honors Life and Legacy of Kobe Bryant - Time Magazine
Democratic Party
Democratic hopefuls now test strength among minority voters - St. Paul Pioneer Press (Minnesota)
The United States Social Security Administration
Union for Reform Judaism, Central Conference of American Rabbis Issue Joint Publ... - Targeted News Service
United States Environmental Protection Agency
Pima offers to swap gas-powered mowers for vouchers - The Arizona Daily Star
Federal Bureau of Investigation
Trump doesn’t heed Barr’s request to cool tweeting on DOJ - The Salt Lake Tribune
Paths to INSERM Transfert SA
Potential Connections via
Relationship Science
You
INSERM Transfert SA
Investments
Details Hidden
Screencell SA

ScreenCell SA offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids. It provides rare cell isolation solutions for medical and research applications. The company was founded on April 11, 2001 by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot and is headquartered in Sarcelles, France.

Details Hidden
Eyevensys SAS

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Details Hidden
Effimune SA

Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by INSERM Transfert SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of INSERM Transfert SA's profile does not indicate a business or promotional relationship of any kind between RelSci and INSERM Transfert SA.